T0	Participants 13 65	locally advanced or metastatic renal cell carcinoma:
T1	Participants 391 481	treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC).
T2	Participants 503 574	Adult patients with measurable, locally advanced, and/or metastatic RCC
T3	Participants 899 995	Of 435 patients enrolled, 233 were treatment naive (54%) and 202 were cytokine pretreated (46%).
T4	Participants 1889 1974	treatment-naive and cytokine-pretreated patients with advanced and/or metastatic RCC.